Stock Expert AI
CBDD company logo

CBDD: AI 评分 51/100 — AI 分析 (4月 2026)

CBD of Denver Inc. focuses on the development and commercialization of cannabidiol (CBD) products, including research, development, and distribution of premium hemp extract products. The company operates as a subsidiary of Swiss Industry Ventures AG.

Key Facts: AI Score: 51/100 Sector: Healthcare

公司概况

概要:

CBD of Denver Inc. focuses on the development and commercialization of cannabidiol (CBD) products, including research, development, and distribution of premium hemp extract products. The company operates as a subsidiary of Swiss Industry Ventures AG.
CBD of Denver Inc. is a cannabidiol (CBD) product company involved in the research, development, and distribution of premium hemp extract products. Operating as a subsidiary of Swiss Industry Ventures AG, the company focuses on commercializing CBD products within the specialty and generic drug manufacturing sector.

CBDD是做什么的?

CBD of Denver Inc., formerly known as Verde Media Group, Inc., was rebranded in 2018 to focus on the burgeoning cannabidiol (CBD) market. The company is dedicated to the research, development, and commercialization of a range of CBD products. Its core business revolves around the creation and distribution of premium hemp extract products, catering to a growing demand for CBD-based solutions. Headquartered in Centennial, Colorado, CBD of Denver Inc. operates as a subsidiary of Swiss Industry Ventures AG, leveraging its parent company's resources and expertise. The company's evolution reflects the increasing acceptance and market potential of CBD in various applications, from wellness to potential therapeutic uses. CBD of Denver Inc. aims to establish itself as a key player in the CBD market by focusing on product quality, innovation, and strategic distribution partnerships. The company's commitment to research and development underscores its ambition to stay at the forefront of CBD advancements and capitalize on emerging opportunities within the healthcare and wellness sectors. CBD of Denver Inc. distributes its products through various channels, targeting both retail consumers and potential business-to-business partnerships.

CBDD的投资论点是什么?

CBD of Denver Inc. presents a speculative investment opportunity within the rapidly evolving CBD market. The company's focus on premium hemp extract products and its position as a subsidiary of Swiss Industry Ventures AG could provide a competitive edge. However, the company's financial performance and market capitalization of $0.00B indicate significant risks. A gross margin of 27.1% suggests potential profitability challenges. The negative beta of -10.69 indicates an inverse correlation with the market, which could be a double-edged sword. Growth catalysts include potential expansion into new product lines and geographic markets. Investors should carefully evaluate the company's OTC status and associated risks before considering an investment.

CBDD在哪个行业运营?

CBD of Denver Inc. operates within the Drug Manufacturers - Specialty & Generic industry, which is experiencing significant growth due to the increasing acceptance and legalization of cannabis and CBD products. The market is characterized by intense competition, with numerous companies vying for market share. The industry is also subject to evolving regulations and consumer preferences. CBD of Denver Inc.'s success depends on its ability to differentiate its products, navigate the regulatory landscape, and establish strong distribution channels. The global CBD market is projected to reach billions of dollars in the coming years, presenting both opportunities and challenges for companies like CBD of Denver Inc.
Drug Manufacturers - Specialty & Generic
Healthcare

CBDD有哪些增长机遇?

  • Expansion into New Therapeutic Areas: CBD of Denver Inc. has the opportunity to expand its product line into new therapeutic areas, such as pain management, anxiety relief, and sleep disorders. The market for CBD-based therapeutic products is growing rapidly, driven by increasing consumer awareness and scientific research. By developing and commercializing targeted CBD formulations, CBD of Denver Inc. can tap into this lucrative market segment and differentiate itself from competitors. This expansion could involve partnerships with healthcare providers and research institutions. The timeline for this growth opportunity is estimated at 2-3 years, with a potential market size of $5 billion.
  • Geographic Expansion: CBD of Denver Inc. can pursue geographic expansion into new markets, both domestically and internationally. The global CBD market is highly fragmented, with significant growth potential in emerging markets. By establishing distribution partnerships and tailoring its product offerings to local preferences, CBD of Denver Inc. can expand its reach and increase its revenue. This expansion could involve entering into joint ventures or acquiring local CBD companies. The timeline for this growth opportunity is estimated at 3-5 years, with a potential market size of $10 billion.
  • Development of Innovative CBD Products: CBD of Denver Inc. can invest in research and development to create innovative CBD products with enhanced efficacy and bioavailability. This could involve developing novel formulations, delivery systems, and extraction methods. By patenting its innovations and establishing a strong intellectual property portfolio, CBD of Denver Inc. can gain a competitive advantage and attract strategic partners. The timeline for this growth opportunity is estimated at 2-4 years, with a potential market size of $3 billion.
  • Strategic Partnerships and Acquisitions: CBD of Denver Inc. can pursue strategic partnerships and acquisitions to expand its capabilities and market reach. This could involve partnering with established healthcare companies, retailers, or distributors. By acquiring complementary businesses, CBD of Denver Inc. can gain access to new technologies, products, and distribution channels. The timeline for this growth opportunity is estimated at 1-3 years, with a potential market size of $2 billion.
  • Focus on Quality and Compliance: CBD of Denver Inc. can differentiate itself by focusing on product quality and regulatory compliance. This involves implementing rigorous quality control measures, obtaining certifications, and adhering to all applicable regulations. By building a reputation for quality and compliance, CBD of Denver Inc. can gain the trust of consumers and healthcare providers. The timeline for this growth opportunity is ongoing, with a potential market size of $1 billion.
  • Market Cap of $0.00B reflects the company's small size and potential volatility.
  • Gross Margin of 27.1% indicates the profitability of CBDD's core operations.
  • Beta of -10.69 suggests an inverse correlation with the broader market.
  • CBDD operates as a subsidiary of Swiss Industry Ventures AG.
  • CBDD focuses on the development and commercialization of cannabidiol (CBD) products.

CBDD提供哪些产品和服务?

  • Develops and commercializes cannabidiol (CBD) products.
  • Engages in the research of hemp extract products.
  • Distributes premium hemp extract products.
  • Focuses on the wellness and potential therapeutic applications of CBD.
  • Operates as a subsidiary of Swiss Industry Ventures AG.
  • Aims to establish a strong presence in the CBD market.

CBDD如何赚钱?

  • Develops and formulates CBD products.
  • Manufactures or outsources the production of CBD products.
  • Distributes CBD products through various channels, including retail and online sales.
  • Generates revenue from the sale of CBD products.
  • Consumers seeking wellness and therapeutic benefits from CBD.
  • Retailers and distributors of CBD products.
  • Healthcare providers interested in CBD-based solutions.
  • Businesses seeking to incorporate CBD into their products.
  • Proprietary CBD formulations and extraction methods.
  • Established distribution network.
  • Strong brand reputation for quality and compliance.
  • Strategic partnerships with key players in the healthcare and wellness industries.

什么因素可能推动CBDD股价上涨?

  • Upcoming: Potential expansion into new therapeutic areas.
  • Upcoming: Geographic expansion into new markets.
  • Upcoming: Development of innovative CBD products.
  • Ongoing: Strategic partnerships and acquisitions.
  • Ongoing: Focus on quality and compliance.

CBDD的主要风险是什么?

  • Potential: Intense competition in the CBD market.
  • Potential: Evolving regulations and consumer preferences.
  • Potential: Negative publicity or product recalls.
  • Potential: Fluctuations in the price of hemp extract.
  • Ongoing: Limited financial resources.

CBDD的核心优势是什么?

  • Focus on premium hemp extract products.
  • Subsidiary of Swiss Industry Ventures AG.
  • Established presence in the CBD market.
  • Commitment to research and development.

CBDD的劣势是什么?

  • Small market capitalization.
  • Limited financial resources.
  • Dependence on the CBD market.
  • OTC market listing.

CBDD有哪些机遇?

  • Expansion into new therapeutic areas.
  • Geographic expansion into new markets.
  • Development of innovative CBD products.
  • Strategic partnerships and acquisitions.

CBDD面临哪些威胁?

  • Intense competition in the CBD market.
  • Evolving regulations and consumer preferences.
  • Potential for negative publicity or product recalls.
  • Fluctuations in the price of hemp extract.

Key Metrics

  • MoonshotScore: 51/100

AI Insight

AI analysis pending for CBDD
  • OTC Tier: OTC Other
  • Disclosure Status: Unknown

常见问题

What does CBD of Denver Inc. do?

CBD of Denver Inc. is involved in the development, research, and distribution of premium hemp extract products. The company focuses on commercializing cannabidiol (CBD) products, catering to the growing demand for CBD-based solutions. Operating as a subsidiary of Swiss Industry Ventures AG, CBD of Denver Inc. aims to establish itself as a key player in the CBD market by focusing on product quality, innovation, and strategic distribution partnerships. The company's products are targeted towards consumers seeking wellness and potential therapeutic benefits from CBD.

What do analysts say about CBDD stock?

As of 2026-03-16, there is no available analyst coverage for CBDD stock. The company's small market capitalization and OTC listing may limit analyst interest. Investors should conduct their own due diligence and consider the company's financial performance, growth prospects, and risk factors before making an investment decision. The lack of analyst coverage increases the uncertainty surrounding the stock's valuation and future performance. The company's gross margin of 27.1% should be considered in any valuation analysis.

What are the main risks for CBDD?

The main risks for CBDD include intense competition in the CBD market, evolving regulations and consumer preferences, potential for negative publicity or product recalls, and fluctuations in the price of hemp extract. The company's small market capitalization and OTC listing also present significant risks. Limited financial disclosure and lack of liquidity further increase the risk of investing in CBDD. Investors should carefully evaluate these risks before considering an investment in the company.

热门股票

查看全部股票 →